Literature DB >> 8986916

Antihypertensive effects and arterial haemodynamic alterations during angiotensin converting enzyme inhibition.

G M London1, B Pannier, E Vicaut, A P Guérin, S J Marchais, M E Safar, J L Cuche.   

Abstract

OBJECTIVE: To assess the respective roles of the anti-hypertensive and blood pressure-independent effects of angiotensin converting enzyme (ACE) inhibition in the changed arterial haemodynamics observed in hypertensive patients with end-stage renal disease (ESRD) treated by haemodialysis. DESIGN AND METHODS: Twelve hypertensive patients with ESRD were included in a double-blind, cross-over study comparing a single 20 mg dose of the ACE inhibitor quinapril versus placebo. Two study periods each of 172 h duration were separated by a 2-week placebo period. Repeated measurements of the following parameters were performed: brachial artery systolic blood pressure (SBP); diastolic blood pressure and mean blood pressure (using a mercury sphygmomanometer); carotid artery SBP and pulse pressure (by applanation tonometry); aortic stiffness (by pulse wave velocity); and the effect of arterial wave reflections in the common carotid artery (the augmentation index, by applanation tonometry). A radioimmunoassay was used to determine plasma angiotensin II levels. Quinaprilat pharmacokinetics were studied using a specific assay. Two-way (time-treatment) analysis of variance for repeated measures, analysis of covariance for two within-factors and a covariate changing with the level of the factor time (pressures measured at each time) and baseline values of the studied parameter as a second covariate were used for statistical analysis.
RESULTS: Quinapril treatment induced a long-lasting decrease in arterial wave reflections, which was still observable 172 h after quinapril administration and still present after removing the effect of the decrease in blood pressure. The effect on wave reflections was associated with a more pronounced and sustained decrease in carotid SBP and pulse pressure than that in brachial SBP and pulse pressure. Quinapril administration also induced a long-lasting decrease in aortic pulse wave velocity, but this effect was entirely dependent on parallel changes in blood pressure. Arterial haemodynamic changes were not related to plasma angiotensin II or quinaprilat levels.
CONCLUSIONS: The results of this controlled study indicate that, in ESRD patients, ACE inhibition results in a long-lasting, blood pressure-independent decrease in arterial wave reflections. The consequence of this was a decrease in pulsatile pressure load in the central arteries with increased aortic distensibility. The increased aortic distensibility resulted from the decrease in blood pressure. The observed arterial haemodynamic alterations suggest that ACE inhibition induced alterations in arterial wave reflections in the distal parts of the arterial tree.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8986916     DOI: 10.1097/00004872-199609000-00015

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  8 in total

Review 1.  Antihypertensive drugs and central blood pressure.

Authors:  Carmel M McEniery
Journal:  Curr Hypertens Rep       Date:  2009-08       Impact factor: 5.369

Review 2.  Arterial stiffness: from physiology to clinical implications.

Authors:  Alberto Milan; Francesco Tosello; Ambra Fabbri; Alessandro Vairo; Dario Leone; Michela Chiarlo; Michele Covella; Franco Veglio
Journal:  High Blood Press Cardiovasc Prev       Date:  2011-03-01

Review 3.  Central blood pressure: current evidence and clinical importance.

Authors:  Carmel M McEniery; John R Cockcroft; Mary J Roman; Stanley S Franklin; Ian B Wilkinson
Journal:  Eur Heart J       Date:  2014-01-23       Impact factor: 29.983

4.  I Luso-Brazilian Positioning on Central Arterial Pressure.

Authors:  Andréa A Brandão; Celso Amodeo; Cristina Alcântara; Eduardo Barbosa; Fernando Nobre; Fernando Pinto; José Fernando Vilela-Martin; José Mesquita Bastos; Juan Carlos Yugar-Toledo; Marco Antônio Mota-Gomes; Mario Fritsch Toros Neves; Marcus Vinícius Bolívar Malachias; Manuel de Carvalho Rodrigues; Oswaldo Passarelli; Paulo César B Veiga Jardim; Pedro Guimarães Cunha; Rui Póvoa; Teresa Fonseca; Vitor Paixão Dias; Weimar Sebba Barroso; Wille Oigman
Journal:  Arq Bras Cardiol       Date:  2017-02-13       Impact factor: 2.000

5.  Comparison of 24-Hour Ambulatory Central Blood Pressure Reduction Efficacy Between Fixed Amlodipine or Up-Titrated Hydrochlorothiazide Plus Losartan: The K-Central Study.

Authors:  Eun Joo Cho; Hae Young Lee; Ki Chul Sung; Sungha Park; Il-Suk Sohn; Chang Gyu Park; Dong-Ju Choi; Jong Won Ha; Young Keun Ahn; Jinho Shin; Soon-Jun Hong; Soon Kil Kim; Wook-Jin Chung; Byung Su Yoo; Taek Jong Hong; Ho Joong Youn; Myeong-Chan Cho; Shung Chull Chae; Young Jo Kim; Chong-Jin Kim
Journal:  Am J Hypertens       Date:  2019-09-24       Impact factor: 2.689

6.  Aldosterone and mortality in hemodialysis patients: role of volume overload.

Authors:  Szu-Chun Hung; Yao-Ping Lin; Hsin-Lei Huang; Hsiao-Fung Pu; Der-Cherng Tarng
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

Review 7.  Manidipine-delapril combination in the management of hypertension.

Authors:  Manuel Luque Otero
Journal:  Vasc Health Risk Manag       Date:  2007

Review 8.  Arterial stiffness and cardiovascular therapy.

Authors:  Miodrag Janić; Mojca Lunder; Mišo Sabovič
Journal:  Biomed Res Int       Date:  2014-08-07       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.